glp-1 and gip dual agonist Tirzepatide's Unique Mechanism of Action Mechanisms of action and therapeutic
Description
Recent policy interventions, such as the Inflation Reduction Act, aimed to expand eligibility for subsidies and cap out-of-pocket costs, but implementation and awareness challenges persist
No Significant Increase in Heart Failure Risk: Concerns regarding an increase in heart failure with saxagliptin, and to a lesser extent alogliptin, resulted in no use or cautious use of these agents in patients with cardiac backgrounds
Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, et al
In these recent studies, the potential risk of hospitalization for HF was significantly increased only in patients taking saxagliptin
Exenatide efficacy and safety: a systematic review
On the other hand, chronically elevating GIP levels in a transgenic mouse model exhibited reduced diet-induced obesity (69)
